2016
DOI: 10.1016/j.jstrokecerebrovasdis.2016.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Poor Hypertension Control and Longer Transport Times Are Associated with Worse Outcome in Drip-and-Ship Stroke Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Similar recommendations were also made by the ESO 49. This blood pressure target was derived from the exclusion criteria in RCTs that examined the effects of thrombolytics in AIS patients, and, while several observational studies have similarly demonstrated an association between elevated systemic blood pressure and hemorrhagic conversion and/or worsened neurological outcomes following tPA, the exact upper-limit blood pressure target remains unclear 90,108–112…”
Section: Aismentioning
confidence: 99%
See 1 more Smart Citation
“…Similar recommendations were also made by the ESO 49. This blood pressure target was derived from the exclusion criteria in RCTs that examined the effects of thrombolytics in AIS patients, and, while several observational studies have similarly demonstrated an association between elevated systemic blood pressure and hemorrhagic conversion and/or worsened neurological outcomes following tPA, the exact upper-limit blood pressure target remains unclear 90,108–112…”
Section: Aismentioning
confidence: 99%
“…49 This blood pressure target was derived from the exclusion criteria in RCTs that examined the effects of thrombolytics in AIS patients, and, while several observational studies have similarly demonstrated an association between elevated systemic blood pressure and hemorrhagic conversion and/or worsened neurological outcomes following tPA, the exact upper-limit blood pressure target remains unclear. 90,[108][109][110][111][112] Anderson et al 113 attempted to address this question in the Enhanced Control of Hypertension and Thrombolysis Stroke (ENCHANTED) study. The ENCHANTED trial was an international, multicenter, prospective RCT in which 2196 alteplase-eligible AIS patients within 6 hours of stroke onset were randomized to either an intensive blood pressure-lowering group (SBP 130 to 140 mm Hg within 1 h) or a guideline treatment group (SBP <180 mm Hg) for 72 hours following tPA administration.…”
Section: Aismentioning
confidence: 99%